Name variants collapsed into this sponsor (2)
- Fundacio Institut De Recerca De L Hospital De La Santa Creu I Sant Pau
- Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau canonical
30
Registered trials
22
Recruiting
3
Completed trials
2
Countries active
47
Unique IMPs
100%
Results reported
100%
3 of 3 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).
Top indications
Top IMPs
IZAFLORTAUCIPIR (18F)
3
BENDAMUSTINE HYDROCHLORIDE
2
CYCLOPHOSPHAMIDE MONOHYDRATE
2
FIBRIN MATRIX
2
FLUDARABINE PHOSPHATE
2
SODIUM CHLORIDE
2
TOCILIZUMAB
2
2-(6-[18F]FLUORO-PYRIDIN-3-YL)-9H-DIPYRIDO[2,3-B:3',4'-D]PYRROLE
1
ACETYLSALICYLIC ACID
1
AFATINIB
1
AMIODARONE HYDROCHLORIDE
1
AMOXICILLIN, CLAVULANIC ACID
1
All trials — page 2
30 total-
HOPE study Ended
Showing 25–30 of 30 trials